Literature DB >> 7507746

Monoclonal antibody against a lactose epitope of glycosphingolipids binds to melanoma tumour cells.

K Ding1, T Ekberg, J Zeuthen, S Teneberg, K A Karlsson, A Rosén.   

Abstract

Mice were immunized with a neoglycoprotein consisting of a chemically modified carbohydrate moiety (reductively aminated 3'-sialyllactose) linked to human serum albumin. By this procedure an antibody response to the normally non-immunogenic carbohydrate structure was obtained. Hybridomas were established, and monoclonal antibodies were selected in ELISA based on their binding to the saccharide hapten, or to a lactosylceramide-mimicking neoglycolipid, lactose-bis-sulfone. One of the selected antibodies, 2H4, was of particular interest, since it also bound to glycolipids present on melanoma cells. FACS analysis of a panel of 14 melanoma cell lines showed that the 2H4 antibody bound to the majority of these. In frozen, non-fixed sections or paraffin sections of biopsies the monoclonal antibody 2H4 stained melanoma cells, but not tumour infiltrating lymphocytes or normal skin. Detailed immunochemical analysis of 2H4, using thin layer chromatography revealed that it recognized an internal lactose epitope in several glycosphingolipids.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7507746     DOI: 10.1007/bf00731044

Source DB:  PubMed          Journal:  Glycoconj J        ISSN: 0282-0080            Impact factor:   2.916


  33 in total

Review 1.  Glycosphingolipids and antitumor immunity.

Authors:  E V Dyatlovitskaya; L D Bergelson
Journal:  Biochim Biophys Acta       Date:  1987-07-08

2.  Preparation of total nonacid glycolipids for overlay analysis of receptors for bacteria and viruses and for other studies.

Authors:  K A Karlsson
Journal:  Methods Enzymol       Date:  1987       Impact factor: 1.600

3.  Requirements for the establishment of high-titered human monoclonal antibodies against tetanus toxoid using the Epstein-Barr virus technique.

Authors:  D Kozbor; J C Roder
Journal:  J Immunol       Date:  1981-10       Impact factor: 5.422

4.  Monoclonal antibody specific for lactosylceramide.

Authors:  F W Symington; I D Bernstein; S Hakomori
Journal:  J Biol Chem       Date:  1984-05-10       Impact factor: 5.157

5.  Antitumor effects of a novel monoclonal antibody with high binding affinity to ganglioside GD3.

Authors:  S Ohta; A Honda; Y Tokutake; H Yoshida; N Hanai
Journal:  Cancer Immunol Immunother       Date:  1993       Impact factor: 6.968

6.  Gangliosides of normal and neoplastic human melanocytes.

Authors:  J M Carubia; R K Yu; L J Macala; J M Kirkwood; J M Varga
Journal:  Biochem Biophys Res Commun       Date:  1984-04-30       Impact factor: 3.575

7.  Inhibition of human melanoma cell growth in vitro by monoclonal anti-GD3-ganglioside antibody.

Authors:  W G Dippold; A Knuth; K H Meyer zum Büschenfelde
Journal:  Cancer Res       Date:  1984-02       Impact factor: 12.701

8.  Immunogenicity of melanoma-associated gangliosides in cancer patients.

Authors:  T Tai; L D Cahan; T Tsuchida; R E Saxton; R F Irie; D L Morton
Journal:  Int J Cancer       Date:  1985-05-15       Impact factor: 7.396

9.  Tumorigenicity in human melanoma cell lines controlled by introduction of human chromosome 6.

Authors:  J M Trent; E J Stanbridge; H L McBride; E U Meese; G Casey; D E Araujo; C M Witkowski; R B Nagle
Journal:  Science       Date:  1990-02-02       Impact factor: 47.728

10.  Studies on the binding of bacteria to glycolipids. Two species of Propionibacterium apparently recognize separate epitopes on lactose of lactosylceramide.

Authors:  N Strömberg; M Ryd; A A Lindberg; K A Karlsson
Journal:  FEBS Lett       Date:  1988-05-09       Impact factor: 4.124

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.